Editorial: Treatment with Dual Incretin Receptor Agonists to Maintain Normal Glucose Levels May Also Maintain Normal Weight and Control Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Worldwide, metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease. MAFLD is associated with insulin resistance, type 2 diabetes mellitus (T2DM), obesity, hypertension, and dyslipidemia. Early diagnosis and management are vital to improving hepatic and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordóñez-Vázquez, Ana Luisa, Beltrán-Gall, Sofía Murúa, Pal, Shreya C., Méndez-Sánchez, Nahum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479660/
https://www.ncbi.nlm.nih.gov/pubmed/36093924
http://dx.doi.org/10.12659/MSM.938365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479660/
https://www.ncbi.nlm.nih.gov/pubmed/36093924
http://dx.doi.org/10.12659/MSM.938365

Ejemplares similares